Literature DB >> 31521857

Varicella outbreak trends in school settings during the voluntary single-dose vaccine era from 2006 to 2017 in Shanghai, China.

Qiang-Song Wu1, Xian Wang1, Jing-Yi Liu1, Yuan-Fang Chen1, Qi Zhou1, Yan Wang1, Ji-da Sha1, Ze-Liang Xuan1, Lin-Wei Zhang2, Lu Yan3, Yi Hu4.   

Abstract

OBJECTIVE: To investigate varicella outbreak trends among schoolchildren during the voluntary single-dose varicella vaccine (VarV) era in Shanghai, China.
METHODS: Trends in school varicella outbreaks from 2006 to 2017 were assessed using joinpoint regression models. The impacts of changes in single-dose VarV coverage among schoolchildren and implementation of post-exposure prophylaxis (PEP) strategies on outbreak trends were further analyzed.
RESULTS: In total, 265 varicella outbreaks involving 3263 cases were reported in Shanghai from 2006 to 2017. The number of outbreaks showed an increasing trend from 2006 to 2017 (t=2.62, p=0.026), especially in kindergartens. The proportion of breakthrough varicella cases among all outbreak-related cases showed an increasing trend from 30.4% in 2008 to 85.7% in 2017 (t=7.45, p<0.001). Single-dose VarV coverage among schoolchildren was 88.1%, and showed a significant increase from the 1996 to the 2008 birth cohorts, followed by a non-significant decline from the 2008 to the 2014 birth cohorts. During school outbreaks in which PEP campaigns were conducted, the varicella attack rate was significantly lower than those in outbreaks without PEP campaigns (1.2% vs. 1.4%; Chi-square=23.35, p<0.001).
CONCLUSIONS: Even with high coverage, single-dose VarV is insufficient to prevent school outbreaks. The administration of VarV as PEP is an appropriate intervention for varicella outbreak control prior to implementing a two-dose VarV schedule.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Breakthrough varicella; Outbreak; Post-exposure prophylaxis; Varicella; Varicella vaccine

Mesh:

Substances:

Year:  2019        PMID: 31521857     DOI: 10.1016/j.ijid.2019.09.009

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  7 in total

1.  Concerns on Vaccine against Varicella Caused by Varicella-Zoster Virus Infection.

Authors:  Wen-Bo Zeng; Fukun Zhang; Shuang Cheng; Jin-Yan Sun; Hongjie Shen; Min-Hua Luo
Journal:  Virol Sin       Date:  2020-05-28       Impact factor: 4.327

2.  Effectiveness of varicella vaccine as post-exposure prophylaxis: a meta-analysis.

Authors:  Daoyong Chen; Yue Li; Qiangsong Wu
Journal:  Hum Vaccin Immunother       Date:  2021-12-10       Impact factor: 3.452

3.  Varicella outbreaks in schools and kindergartens in Shanghai, China from 2011 to 2020.

Authors:  Jing Wang; Zhenhui Xu; Qiang Gao
Journal:  PLoS One       Date:  2022-06-30       Impact factor: 3.752

4.  Upgrading the school entry vaccination record check strategy to improve varicella vaccination coverage: results from a quasi-experiment study.

Authors:  Wei Qin; Jian Song; Yao Wang; Tingyue Nie; Fan Pan; Xiaokang Xu; Hailin Tao; Xiangmei Meng; Ruyu Ni; Shishi Cheng; Shaoyu Xie; Hong Su
Journal:  Hum Vaccin Immunother       Date:  2021-05-21       Impact factor: 3.452

5.  Epidemiological characteristics of varicella outbreaks in the Republic of Korea, 2016-2020.

Authors:  Eun-Young Kim; Chungmin Park; Gyehee Lee; Suyeon Jeong; Jeongsuk Song; Dong-Han Lee
Journal:  Osong Public Health Res Perspect       Date:  2022-04-26

6.  Detection of Circulating VZV-Glycoprotein E-Specific Antibodies by Chemiluminescent Immunoassay (CLIA) for Varicella-Zoster Diagnosis.

Authors:  Arnaud John Kombe Kombe; Jiajia Xie; Ayesha Zahid; Huan Ma; Guangtao Xu; Yiyu Deng; Fleury Augustin Nsole Biteghe; Ahmed Mohammed; Zhao Dan; Yunru Yang; Chen Feng; Weihong Zeng; Ruixue Chang; Keyuan Zhu; Siping Zhang; Tengchuan Jin
Journal:  Pathogens       Date:  2022-01-05

7.  Changes in epidemiological features of vaccine preventable infectious diseases among three eras of national vaccination strategies from 1953 to 2018 in Shanghai, China.

Authors:  Qiangsong Wu; Maryam Zaid; Zeliang Xuan; Chenxi Wang; Haiyan Gu; Min Shi; Jiahui Zhu; Yi Hu; Jingyi Liu
Journal:  Lancet Reg Health West Pac       Date:  2021-01-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.